GoodRx Holdings, Inc.
NASDAQ:GDRXMedical - Healthcare Information Services
+$0.05 today
- Market cap
- $1.15B
- Beta
- 1.61
- P/E (TTM)
- 44.0
- EPS (TTM)
- $0.06
Volume 0.66M
Average 1.61M
GDRX Long-term Debt
Borrowings due after more than one year.
GoodRx Holdings, Inc.NASDAQ: GDRX
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt broadly unchanged from a year ago
Long-term debt stood at $482.42M at the end of Q1 FY2026, down 0.7% from a year earlier and down 0.2% from the prior quarter. Over 3 fiscal years it compounded at -9.5% a year.
Context
- Long-term debt amounted to 23.9% of total assets at the end of Q1 FY2026, down 13.6 pp from a year earlier.
- Long-term debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term debt keeps falling in the next quarterly balance sheet after a -0.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 483.26M USD
- Year-over-year change
- -0.7%
- 4-year CAGR
- -7.4%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 483.26M | -0.7% |
| FY2024 | 2024-12-31 | 486.71M | -24.9% |
| FY2023 | 2023-12-31 | 647.7M | -0.6% |
| FY2022 | 2022-12-31 | 651.8M | -0.6% |
| FY2021 | 2021-12-31 | 655.86M | — |
Long-term Debt vs competitors
How GDRX compares with its peers on the latest reported figures
- GDRX's Mar 2026 long-term debt of $482.42M is the 2nd highest of the 4 companies compared; the peer median is $5.5M.
- Its year-over-year change of -0.7% is the 2nd highest of 3, against a peer median of -9.5%.
- Long-term debt amounts to 23.9% of total assets for GDRX, versus a peer median of 7.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $995.81M | +0.4% | -13.5% | 35.5% | |
| Mar 2026 | $482.42M | -0.7% | -9.5% | 23.9% | |
| Mar 2026 | $5.5M | -19.3% | — | 7.8% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GDRX) | $5.5M | -9.5% | -13.5% | 7.8% | |
Competitors are the stored peer set for GDRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 941.11M | 757.17M | 672.3M | 448.35M | 261.82M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 126.41M | 121.67M | 160.05M | 160.83M | 254.87M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 21.31M | 35.11M | 40.45M | 50.08M | 126.41M |
| Total Current Assets | 1.09B | 919.69M | 872.79M | 659.26M | 643.1M |
| Property, Plant & Equipment (Net) | 49.32M | 55.73M | 45.86M | 40.46M | 41.08M |
| Goodwill | 329.7M | 412.12M | 410.77M | 410.77M | 430.33M |
| Intangible Assets | 133.78M | 189.94M | 156.34M | 176.88M | 203.34M |
| Long-term Investments | 4M | 19M | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 65.27M | 77.18M | 57.11M |
| Other Non-current Assets | 2.01M | 8.17M | 37.78M | 23.52M | 29.1M |
| Total Non-current Assets | 518.8M | 684.95M | 716.01M | 728.81M | 760.96M |
| Total Assets | 1.61B | 1.6B | 1.59B | 1.39B | 1.4B |
| Account Payables | 17.5M | 17.7M | 36.27M | 14.14M | 19.41M |
| Short-term Debt | 7.03M | 7.03M | 8.79M | 5M | 5M |
| Tax Payables | 0 | 0 | 0 | 1.46M | 0 |
| Deferred Revenue | 6.87M | 7.88M | 7.11M | 6.04M | 6.71M |
| Other Current Liabilities | 0 | 0 | 0 | 15.8M | 130.14M |
| Total Current Liabilities | 81.11M | 76.32M | 122.56M | 123.9M | 246M |
| Long-term Debt | 655.86M | 651.8M | 647.7M | 486.71M | 483.26M |
| Deferred Tax Liabilities | 244K | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 5.14M | 7.56M | 8.18M | 6.76M | 8.74M |
| Total Non-current Liabilities | 694.83M | 713.48M | 704.28M | 539.51M | 541.79M |
| Total Liabilities | 775.95M | 789.8M | 826.84M | 663.41M | 787.8M |
| Common Stock | 40K | 40K | 40K | 38K | 34K |
| Retained Earnings | (1.42B) | (1.45B) | (1.46B) | (1.44B) | (1.41B) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 831.68M | 814.83M | 761.96M | 724.66M | 616.26M |
| Total Debt | 702.33M | 717.02M | 711.07M | 543.39M | 542.81M |
| Net Debt | (238.78M) | (40.14M) | 38.77M | 95.04M | 280.99M |
GoodRx Holdings, Inc.
NASDAQ:GDRX
Intrinsic Alpha fair value
Locked
Current Price
$3.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.